Regulatory insights on adeno-associated virus-based gene therapies, cell- and tissue-based products, and CAR-T cell therapies: report from the 8th Asia Partnership Conference of Regenerative Medicine, April 24, 2025
{{output}}
The 8th Asia Partnership Conference of Regenerative Medicine (APACRM) was held in a hybrid format-both in person and online-on April 24, 2025, to advance regulatory harmonization for regenerative medicine products across Asia. Understanding the domestic regula... ...
